XM does not provide services to residents of the United States of America.

Futures up ahead of economic data, TSMC results lift chip stocks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Futures up ahead of economic data, TSMC results lift chip stocks</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

TSMC gains after forecasting Q4 revenue jump

Elevance Health down after cutting annual profit forecast

Futures up: Dow 0.07%, S&P 500 0.41%, Nasdaq 0.83%

Updated at 07:03 a.m. ET/1103 GMT

By Lisa Pauline Mattackal and Purvi Agarwal

Oct 17 (Reuters) - U.S. stock index futures advancedon Thursday, with an upbeat forecast from TSMC boosting semiconductorstocks, while investors awaited key economic data for clues on the U.S. consumer's financial health.

Profit at Taiwan Semiconductor Manufacturing Co 2330.TW, theworld's largest contract chipmaker, beat market estimates and the company forecast a jump in fourth-quarter revenue, driven by demand for artificial intelligence chips.

The chipmaker's U.S.-listed shares TSM.N soared 8% in premarket trading, while AI-trade favorite Nvidia NVDA.O gained 2.6%.

Other chip stocks such as BroadcomAVGO.O rose 2.7%, Intel INTC.O gained 1.3% and Arm Holdings ARM.O was 3.6% higher.

Stocks had advanced in Wednesday's session, with the Dow Jones Industrial Average .DJI notching up its third record close in four sessions, as declines in megacap tech stocks were offset by a rally in small-cap and financial shares.

Futures tracking the small-cap Russell 2000 RTYcv1 were slightly lower, down 0.1%, after the index closed at its highest level in nearly three years.

Megacap stocks rose after broad declines in the previous session, with Apple AAPL.O rising 0.8% and Microsoft <MSFT.O> up 0.6%.

Focus now turns to the U.S. economic outlook, with September retail sales and industrial production, as well as weekly jobless claims data due on the day.

"Growth indicators in the US are now being closely monitored by the market and in terms of retail sales, a slight recovery is expected in September after sales slowed in August," analysts at SEB Research said in a note.

Dow E-minis 1YMcv1 were up 29 points, or 0.07%, S&P 500 E-minis EScv1 were up 24.25 points, or 0.41% and Nasdaq 100 E-minis NQcv1 were up 169.5 points, or 0.83%.

Another busy day of corporate earnings lies ahead, with streaming giant Netflix NFLX.O scheduled to report third-quarter earnings after the bell. Its shares rose 0.4% in premarket trading.

Elevance Health ELV.N plummeted 12.6% after the health insurer slashed its full-year profit forecast, expecting to pay out more in claims due to robust demand for medical care.

Peers UnitedHealth UNH.N slipped 1.3%, Humana HUM.N fell 3%, while Centene CNC.N was off 6%.

A broadly upbeat start to the third-quarter earnings season, on the heels of strong economic data and the U.S. Federal Reserve kicking off its policy-easing cycle, injected fresh optimism into equity markets.

This propelled the benchmark index to fresh record highs and closer to the psychologically important 6,000 mark.

Still, analysts have flagged increasingly stretched valuations, high earnings expectationsand likely volatility ahead of November's U.S. presidential election as risk factors through the end of the year.

Federal Reserve Bank of Chicago President Austan Goolsbee is also scheduled to speak later in the day.

The Fed is still widely expected to trim rates by 25 basis points at its next meeting in November, according to CME's FedWatch.

EV-maker Lucid LCID.O tumbled 15.6% after it said it expects to report a bigger-than-expectedloss for the third quarter and announced a public offering of more than 262 million shares.



Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru; Editing by Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.